UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 166

Sortiert nach

A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas: a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network

British journal of cancer, 2012-07, Vol.107 (2), p.280-286

2012

Volltextzugriff (PDF)

RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38

Cell death & disease, 2014-07, Vol.5 (7), p.e1318-e1318

2014

Volltextzugriff (PDF)

Discrepant NOXA (PMAIP1) transcript and NOXA protein levels: a potential Achilles' heel in mantle cell lymphoma

Cell death & disease, 2014-01, Vol.5 (1), p.e1013-e1013

2014

Volltextzugriff (PDF)

Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma

Leukemia, 2007-06, Vol.21 (6), p.1183-1188

2007

Volltextzugriff (PDF)

Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer

The New England journal of medicine, 2015-02, Vol.372 (8), p.724-734

2015

Volltextzugriff (PDF)

Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial

Leukemia, 2011-03, Vol.25 (3), p.420-428

2011

Volltextzugriff (PDF)

Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer

The New England journal of medicine, 2012-01, Vol.366 (2), p.109-119

2012

Volltextzugriff (PDF)

Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL)

Annals of oncology, 2006-10, Vol.17 (10), p.1546-1552

2006

Volltextzugriff (PDF)

Pharmacological inhibition of c-Abl compromises genetic stability and DNA repair in Bcr-Abl-negative cells

Oncogene, 2008-07, Vol.27 (31), p.4380-4384

2008

Volltextzugriff (PDF)

Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial

Leukemia, 2015-05, Vol.29 (5), p.1060-1068

2015

Volltextzugriff (PDF)

Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study

Annals of oncology, 2001-11, Vol.12 (11), p.1619-1630

2001

Volltextzugriff (PDF)

A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV

European journal of cancer (1990), 2015-01, Vol.51 (1), p.27

2015

Volltextzugriff (PDF)

Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines

Blood, 2000-09, Vol.96 (5), p.1933-1939

2000

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations

Annals of oncology, 2017-11, Vol.28 (11), p.2793-2798

2017

Volltextzugriff (PDF)

Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation

Bone marrow transplantation (Basingstoke), 1997-01, Vol.19 (2), p.143-147

1997

Volltextzugriff (PDF)

Identification of the NO synthase isoforms expressed in human neutrophil granulocytes, megakaryocytes and platelets

Thrombosis and haemostasis, 1997-01, Vol.77 (1), p.163

1997

Volltextzugriff (PDF)

Role of poly(ADP-ribose) polymerase activity in imatinib mesylate-induced cell death

Cell death and differentiation, 2005-06, Vol.12 (6), p.627-636

2005

Volltextzugriff (PDF)

Interferon-α Stimulates Production of Interleukin-10 in Activated CD4+ T Cells and Monocytes

Blood, 1996-06, Vol.87 (11), p.4731-4736

1996

Volltextzugriff (PDF)

Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell transplantation

Annals of hematology, 2002-06, Vol.81 (6), p.343-346

2002

Volltextzugriff (PDF)

Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gamma

Journal of clinical oncology, 1989-12, Vol.7 (12), p.1875-1884

1989

Volltextzugriff (PDF)

Induction of circulating IL-1 receptor antagonist by IFN treatment

The Journal of immunology (1950), 1993-05, Vol.150 (10), p.4687

1993

Volltextzugriff (PDF)

Phase I trial of inhaled natural interleukin 2 for treatment of pulmonary malignancy: toxicity, pharmacokinetics, and biological effects

Clinical cancer research, 1996-07, Vol.2 (7), p.1115-1122

1996

Volltextzugriff (PDF)

Primary proliferating immature myeloid cells from CML patients are not resistant to induction of apoptosis by DNA damage and growth factor withdrawal

British journal of haematology, 1996-12, Vol.95 (3), p.501-507

1996

Volltextzugriff (PDF)

Phase I Study of Subcutaneously Administered Recombinant Human Interleukin 12 in Patients with Advanced Renal Cell Cancer

Clinical cancer research, 1999-12, Vol.5 (12), p.3983-3989

1999

Volltextzugriff (PDF)

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2010-09, Vol.304 (10), p.1073

2010

Volltextzugriff (PDF)

1 – 25 von 166

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(123)

Publikationsform

Sprache

Englisch
(151)
Japanisch
(17)
Deutsch
(13)

Erscheinungsjahr

n.n

Thema

Humans
(122)
Life Sciences & Biomedicine
(118)
Science & Technology
(118)
Biological And Medical Sciences
(69)
Medical Sciences
(62)
Middle Aged
(61)
Adult
(58)
Male
(56)
Female
(49)
Hematology
(45)
Oncology
(43)
Aged
(37)
Pharmacology. Drug Treatments
(36)
Antineoplastic Agents
(23)
Immunology
(22)
Adolescent
(21)
Immunotherapy
(18)
Treatment Outcome
(18)
Hematologic And Hematopoietic Diseases
(17)
Animals
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas: a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network

RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38

Discrepant NOXA (PMAIP1) transcript and NOXA protein levels: a potential Achilles' heel in mantle cell lymphoma

Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma

Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer

Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial

Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer

Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL)

Pharmacological inhibition of c-Abl compromises genetic stability and DNA repair in Bcr-Abl-negative cells

Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial

Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study

A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV

Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines

Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations

Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation

Identification of the NO synthase isoforms expressed in human neutrophil granulocytes, megakaryocytes and platelets

Role of poly(ADP-ribose) polymerase activity in imatinib mesylate-induced cell death

Interferon-α Stimulates Production of Interleukin-10 in Activated CD4+ T Cells and Monocytes

Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell transplantation

Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gamma

Induction of circulating IL-1 receptor antagonist by IFN treatment

Phase I trial of inhaled natural interleukin 2 for treatment of pulmonary malignancy: toxicity, pharmacokinetics, and biological effects

Primary proliferating immature myeloid cells from CML patients are not resistant to induction of apoptosis by DNA damage and growth factor withdrawal

Phase I Study of Subcutaneously Administered Recombinant Human Interleukin 12 in Patients with Advanced Renal Cell Cancer

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

Suchergebnisse filtern